Our policy in the Medical Programs Department of the National Psoriasis Foundation (NPF) is to ensure balance, independence, objectivity, and scientific rigor in all our educational programs. Anyone presenting or participating in the planning of any NPF CME programs is expected to disclose to the Medical Programs Department any real or apparent affiliation(s) within the past 12 months that may have a direct bearing on the subject matter of the continuing medical education program. The intent of this policy is to ensure continuing medical education programs that are free of commercial interests.
Joseph Merola, MD, MSSC has served as a consultant/advisor for Biogen IDEC, AbbVie, Amgen, Eli Lilly and Company, Novartis, Pfizer, Janssen, UCB, Kiniksa, and Momenta and Mallinckrodt, Sumumed. He has served as a clinical study investigator for Biogen IDEC, Amgen, Pfizer and Boehringer Ingelheim. He is on the advisory board for Biogen IDEC, AbbVie, Amgen, Eli Lilly and Company, Novartis, Pfizer, Janssen, UCB, Kiniksa, and Momenta and Mallinckrodt. He has served as a speaker for AbbVie.
Planning Committee: Andi Agnew has disclosed no relevant financial interests with any commercial interests.